동향
동향 내용
PHARMACOKINETIC MODELING OF LAMIVUDINE AND ZIDOVUDINE TRIPHOSPHATES PREDICTS DIFFERENTIAL PHARMACOKINETICS IN SEMINAL MONONUCLEAR CELLS AND PBMCS.
분류 pharmacokinetics 조회 2286
발행년도 2015 등록일 2015-10-17
출처 Antimicrob Agents Chemother (바로가기)
The male genital tract is a potential site of viral persistence. Therefore, adequate concentrations of antiretrovirals are required to eliminate HIV replication in the genital tract. Despite higher zidovudine (ZDV) and lamivudine (3TC) concentrations in seminal plasma (SP) compared to blood plasma (BP) (SP:BP concentration ratios of 2.3 and 6.7, respectively), we have previously described lower relative intracellular concentrations of their active metabolites, zidovudine triphosphate (ZDV-TP) and lamivudine triphosphate (3TC-TP), in seminal mononuclear cells (SMCs) compared to peripheral blood mononuclear cells (PBMCs) (SMC:PBMC concentration ratios of 0.36 and 1.0, respectively). Here, we use population PK modelling-based methods to simultaneously describe parent and intracellular metabolite PK in blood, semen, and PBMCs and SMCs. From this model, time to steady-state in each matrix was estimated, and indicates that the PK of 3TC-TP and ZDV-TP in PBMC are different compared to SMC, and different between the two triphosphates.
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Oritavancin Pharmacokinetics and Bone Penetration in Rabbits.
다음글다음글 Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients.